TRANSIPURE
Food supplement declared in France, declaration No 2016-9-811, decision dated 30 September 2016
TRANSIPURE (HTA CARE) is a food supplement declared in France. Status: déclaré en France, commercialisation possible : l'administration ne s'est pas opposée à la déclaration (ce n'est ni une autorisation ni une évaluation de sécurité). None of the rules we check flags an issue with its declared composition; vitamin and mineral doses are not published by Compl'Alim and are therefore not checked.
- Brand
- HTA CARE
- Food business operator placing the product on the market
- SUD ESTHETIQUE
- Status
- Déclaré en France, commercialisation possible : l'administration ne s'est pas opposée à la déclaration (ce n'est ni une autorisation ni une évaluation de sécurité)
- Form
- Gélule
- Daily dose
- 6 gélules
- Directions for use
- 3 à 6 gélules par jour réparties en 2 prises avec un grand verre d’eau, 10 minutes avant les repas
- Objectives stated by the manufacturer (these are not authorised claims)
- Transit
Declaration 276252, procedure Article 16. Compl'Alim, food supplement declarations (France), retrieved 23 October 2026.
Regulatory points
None of the rules we check applies to the declared ingredients.
Declared composition
Other active ingredients
| Name | Per day |
|---|---|
| Charbon végétal | not declared |
Micro-organisms
| Strain | Per day |
|---|---|
| Saccharomyces Cerevisiae Saccharomyces cerevisiae | 675 (unit not declared) |
List from the declaration, administrative decision dated (Compl'Alim, food supplement declarations (France)).
List recorded in 2016. Photograph the packaging to check whether it has changed.
Has the product changed? Photograph the packaging.
This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.
Brand : HTA CARE